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Transfer RNA biogenesis: A visa to leave the nucleus?
George Simos and Ed Hurt
Only correctly folded and mature tRNAs can leave the
nucleus and enter the cytoplasm. Surprisingly, tRNA-
aminoacylation has been found to occur, not only in the
cytosol, but also inside the nucleus, where it may act as
an additional proofreading step and facilitate the
export of ‘ready-to-function’ aminoacyl-tRNAs.
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The biogenesis of mature transfer (t)RNAs in cells has a
complexity that belies the elegance of their function as
the adaptor molecules of protein synthesis. They are syn-
thesized as precursors which are converted to mature
tRNA molecules by a sequence of events that includes
processing of their 5′ and 3′ ends, modification of a
number of bases, addition of the terminal CCA residues
and, in the case of intron-containing tRNAs, splicing
(reviewed in [1]). Early experiments involving micro-
injection into Xenopus oocyte nuclei showed that these
maturation events occur inside the nucleus [2]; further-
more, they were suggested to take place in an ordered
fashion, with 5′-end and 3′-end processing preceding
intron removal. 
Lund and Dahlberg [3] have now changed this view, with
evidence that tRNA splicing normally occurs before end-
maturation. They have further shown that correctly
processed termini are required for export of tRNA from
the nucleus [3]. Their most unexpected finding, however,
is that tRNAs can be aminoacylated — charged with their
cognate amino acids — inside the nucleus. This has a
functional significance, as non-aminoacylated tRNAs are
exported into the cytoplasm at a slower rate than the
corresponding charged tRNAs. This importance of tRNA
end-maturation for nuclear tRNA export has been
independently observed by Mattaj and co-workers [4] in
the course of their study of the structural requirements for
binding of tRNA to its nuclear export receptor.
More than a decade ago [5], nuclear export of tRNA was
shown to be a carrier-mediated and active transport process,
sensitive to mutations that destabilize the conserved tRNA
tertiary structure or severely impair its processing. It was
only last year, however, that a nuclear export receptor for
tRNA was characterised in yeast and mammalian cells
[6–9]. This receptor, a member of the importin β family
known as Xpo-t (Los1 in yeast), displays all the properties
expected of an ‘exportin’ — such as association with the
nuclear pores and dependence on Ran–GTP for binding to
cargo molecules — but differs from the other exportins that
have been characterized so far in recognizing an RNA mol-
ecule rather than a protein (for a recent review of nucleo-
cytoplasmic transport see [10]).
With the tRNA nuclear export receptor Xpo-t in hand,
Mattaj and colleagues [4] went on to systematically charac-
terize the structural requirements for interaction between
tRNA and Xpo-t, attempting to correlate the results with
the prerequisites for efficient nuclear export of tRNA. The
parts of a tRNA molecule that interact directly with Xpo-t
were identified by their protection against chemical modi-
fication in the Xpo-t–Ran–GTP complex; these probing
experiments showed that the acceptor and TΨC arms of a
tRNA molecule form the main interface with Xpo-t. A
‘minihelix’ consisting of these elements did not bind to
Xpo-t, however; indeed, testing mutant tRNAs for binding
to Xpo-t in vitro and export in vivo showed that both
required correct tertiary folding, as well as mature 5′ and
3′ ends, including the addition of the CCA at the 3′ end. 
These results provide an answer to the long-standing
question of why pre-tRNAs with unprocessed ends or an
abnormal structure cannot escape from the nucleus. These
pre-tRNAs have low affinity for the export receptor and
therefore no access to the nuclear export pathway. But this
does not apply to unspliced pre-tRNAs: an intron-contain-
ing pre-tRNA binds as well to Xpo-t–Ran–GTP as does a
mature tRNA. Nevertheless, the nuclear export of this
unspliced tRNA is poor, unless excess Xpo-t is co-injected
into the oocyte nucleus [4]. These observations can be
explained by the recent findings of Lund and Dahlberg [3]. 
Lund and Dahlberg [3] have found that when low, and
therefore physiologically relevant, amounts of pre-tRNAs
are injected into the oocyte nucleus, splicing is kinetically
favored and occurs prior to removal of terminal sequences.
Under physiological conditions, therefore, the only cargo
available to the tRNA export machinery may be spliced
tRNA molecules. But the tRNA splicing machinery appears
to be easily saturated when large amounts of pre-tRNAs are
present, leading to accumulation of unspliced, but other-
wise mature, tRNAs. Only under these artificial conditions
can the excess of the intron-containing tRNAs access the
nuclear export machinery and thereby escape into the cyto-
plasm. It should, however, be kept in mind that mutant
yeast cells that are defective in tRNA nuclear export, such
as los1 or rna1-1 cells, accumulate intron-containing but
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end-matured pre-tRNAs inside the nucleus [9]. This sug-
gests that the yeast tRNA nuclear export machinery may
somehow be coupled to the splicing machinery (for further
discussion see [1]).
The observation that the tRNA export machinery accepts
the presence of introns, but requires maturation at the 5′
and 3′ ends as well as attachment of the CCA 3′ terminal
sequence — in other words, the formation of a functional
amino acid acceptor helix — prompted Lund and
Dahlberg [3] to test whether tRNAs have to be amino-
acylated in order to be exported from the nucleus. Despite
the fact that some components of the aminoacylation
machinery have previously been detected in the nucleus
(reviewed in [11]), tRNA-aminoacylation has been
thought to be a strictly cytoplasmic process. However,
Lund and Dahlberg have been able to demonstrate that
tRNAs injected in Xenopus oocyte nuclei are charged with
their cognate amino acids before leaving the nucleus. 
Lund and Dahlberg [3] found that, even under conditions
where tRNA export was blocked by depletion of nuclear
Ran–GTP, the injected tRNAs were aminoacylated,
proving that aminoacylation was actually taking place
inside the nucleus. Specific inhibitors of aminoacylation
not only abolished intranuclear (in addition to cytoplasmic)
Figure 1
The tRNA biogenesis pathway, highlighting
recent findings and open questions. Precursor
tRNAs are transcribed in the nucleus and
undergo first splicing, if they contain introns,
and then processing of their 5′ and 3′ ends
and CCA addition at the 3′ end. Only these
resulting mature tRNAs bind with high affinity
to the tRNA nuclear export receptor
(Los1/Xpo-t) in the presence of Ran–GTP [4]
(1). The tRNA–Xpo-t–Ran–GTP complex is
translocated to the cytoplasm through the
nuclear pores and, on hydrolysis of GTP, it
dissociates releasing the tRNA. In the light of
the recent findings of Lund and Dahlberg [3]
discussed in the text, alternative pathways are
possible. Mature tRNAs can be aminoacylated
inside the nucleus and then delivered to the
Xpo-t–Ran–GTP complex for export (2). In
this case, export of aminoacylated tRNAs is
facilitated either because they have a higher
affinity for Xpo-t or because their interaction
with Xpo-t is stimulated by another
component. Aminoacylated tRNAs may also
follow a Xpo-t-independent pathway out of the
nucleus (3), involving as yet unidentified
factors. In the case of pathways (2) and (3),
aminoacyl-tRNAs that exit the nucleus can be
directly used by the protein translation
machinery. Intranuclear tRNA-aminoacylation
also implies that components of the
aminoacylation machinery, including
aminoacyl-tRNA synthetases (AARSs) and co-
factors (Arc1/p43), must be imported into the
nucleus, a process about which nothing is
known. AA, aminoacyl-group.
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aminoacylation, but also led to significant retardation in
the nuclear export of the non-aminoacylated tRNA [3].
Intranuclear aminoacylation of tRNA was also detected by
Mattaj and co-workers [4], who additionally found that
mutant tRNAs that cannot be aminoacylated are exported
from oocyte nuclei at a lower rate than wild-type tRNAs.
At least one of these mutant tRNAs, however, binds to
Xpo-t–Ran–GTP as efficiently as a wild-type tRNA. 
How important is aminoacylation for tRNA’s association
with the components of the nuclear export machinery?
Although the effect of aminoacylation on the interaction
of a tRNA with Xpo-t has not yet been directly tested, the
fact that non-aminoacylated tRNAs bind with high affinity
to Xpo-t suggests that aminoacylation is not required for
this interaction. Furthermore, as mentioned above, intron-
containing pre-tRNAs also interact with Xpo-t and can be
eventually exported from the nucleus, despite the fact
that these tRNAs should be very poor substrates for their
corresponding aminoacyl-tRNA synthetases [3,4].
Several hypotheses could explain these observations.
Firstly, a small difference in the affinity of aminoacylated
versus non-aminoacylated tRNAs for Xpo-t in vitro might
be amplified and become significant in vivo, where a
plethora of RNA species have to compete for binding to
Xpo-t. Secondly, the delivery of aminoacyl-tRNAs to
Xpo-t might be facilitated in vivo by the aminoacyl-tRNA
synthetases or other proteins that specifically interact with
charged tRNAs. Lastly, the effect of aminoacylation on
nuclear export of tRNAs might not be related to their
affinity for Xpo-t; there might be an additional tRNA
nuclear export pathway that does not involve Xpo-t and is
sensitive to the aminoacylation state of the transported
tRNAs (see also Figure 1). 
Some evidence against this last possibility has come from
the work of Mattaj and colleagues [4], who found that
injection of antibodies against Xpo-t into Xenopus oocyte
nuclei significantly inhibited tRNA nuclear export. This
observation indicates that Xpo-t is the major tRNA export
receptor in Xenopus oocytes. So even if an alternative
Xpo-t-independent tRNA nuclear export pathway does
exist, it could play only a minor role in Xenopus oocytes.
But the rapid growth of cells or organisms might conceiv-
ably demand a higher nuclear tRNA export rate, and it is
very unlikely that this could be provided by simple diffu-
sion of tRNA out of the nucleus, so an additional — and
possibly tRNA-aminoacylation-dependent — export mech-
anism might come into operation at other developmental
stages. This might especially be true for yeast, as Los1 —
the Saccharomyces cerevisiae homologue of Xpo-t — is not
required for cell viability. 
Interestingly, Los1 does become essential for yeast cell
growth if aminoacylation or translation factors, such as Arc1
or eIF-2γ, are mutated [7,12]. Arc1, which is present mainly
in the cytoplasm, associates with at least two aminoacyl-
tRNA synthetases and promotes the efficient interaction
with their cognate tRNAs; eIF-2γ is the γ subunit of
eukaryotic protein translation initiation factor 2, which
binds to the charged initiator tRNAMet. The genetic inter-
action of Arc1 and eIF-2γ with Los1 might simply reflect
their involvement in transport of newly exported tRNAs to
the cytosolic aminoacylation and translation machineries,
respectively. But it is also possible that eIF-2γ, Arc1 or any
other protein that binds to aminoacyl-tRNAs — such as
elongation factor eEF-1α — might promote the nuclear
export of tRNA [3]. These factors might either act in
concert with Los1/Xpo-t or be components of a redundant
Los1/Xpo-t-independent, but aminoacylation-dependent,
nuclear tRNA export pathway (Figure 1).
Another issue raised by the finding of intranuclear tRNA
aminoacylation is how aminoacyl-tRNA synthetases gain
access to the nuclear interior. Although the structures and
properties of these enzymes have been extensively inves-
tigated, with a few exceptions their subcellular location
has been little studied. Indeed, the few aminoacyl-tRNA
synthetases that have been immunocytologically localized
were detected inside the nucleus, in addition to their pre-
dominant localization in the cytoplasm (reviewed in [11]).
One would expect that, if the twenty aminoacyl-tRNA
synthetases are transported into the nucleus, then they
should all contain nuclear localization sequences (NLSs).
But they must not be allowed to accumulate inside the
nucleus, as their major site of activity is the cytoplasm
where the bulk of tRNA resides. This can be achieved by
regulating the nucleocytoplasmic transport of the amino-
acyl-tRNA synthetases, for example by also using nuclear
export sequences (NESs) that would allow them to shuttle
between nucleus and cytoplasm. 
The catalytic domains of aminoacyl-tRNA synthetases are
generally well conserved between prokaryotes and
eukaryotes. It is possible that there might be NLSs or
NESs in the non-catalytic domains or extensions that are
characteristic of the eukaryotic enzymes. These domains
have also been implicated in the organization of supra-
molecular assemblies, such as the mammalian 1100 kDa
‘multisynthetase complex’, which contains nine amino-
acyl-tRNA synthetases as well as three non-catalytic com-
ponents, one of which, p43, is the mammalian homologue
of Arc1 [11,12]. Tracking down the movement of this 
particle in and out of the nucleus should certainly be a
challenging task for cell biologists.
In summary, the recent studies that we have reviewed
suggest that, at least in Xenopus oocytes, the final step of
intranuclear tRNA maturation is aminoacylation, which
might act as a proofreading mechanism to ensure the struc-
tural integrity of exported tRNAs, as well as to promote
their efficient transport into the cytoplasm. This unex-
pected finding makes us realise how much more we still
have to learn about basic cellular processes, such as tRNA-
aminoacylation, which we thought we understood so well.
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If you found this dispatch interesting, you might also want
to read the April 1999 issue of
Current Opinion in
Genetics & Development
which will include the following reviews,
edited by James T Kadonaga and Michael
Grunstein, on Chromosomes and
expression mechanisms:
RNA polymerase II as a control panel for multiple
coactivator complexes
Michael Hampsey and Danny Reinberg
Coactivator and corepressor complexes in nuclear
receptor function
Lan Xu, Christopher K Glass and Michael G Rosenfeld
Chromatin-modifying and -remodeling complexes
Roger D Kornberg and Yahli Lorch
Activation by locus control regions?
Frank Grosveld
DNA methylation and chromatin modification
Huck-Hui Ng and Adrian Bird
Mechanisms of genomic imprinting
Camilynn I Brannan and Marisa S Bartolomei
Histone acetylation and cancer
Sonia Y Archer and Richard A Hodin
Modifying chromatin and concepts of cancer
Sandra Jacobson and Lorraine Pillus
Chromatin assembly: biochemical identities and
genetic redundancy
Christopher R Adams and Rohinton T Kamakaka
Stopped at the border: boundaries and insulators
Adam C Bell and Gary Felsenfeld
Nuclear compartments and gene regulation
Moira Cockell and Susan M Gasser
Centromere proteins and chromosome inheritance: 
a complex affair
Kenneth W Dobie, Kumar L Hari, Keith A Maggert 
and Gary H Karpen
Telomeres and telomerase: broad effects on cell
growth
Carolyn M Price
In vivo methods to analyze chromatin
Robert T Simpson
The full text of Current Opinion in Genetics &
Development is in the BioMedNet library at
http://BioMedNet.com/cbiology/gen
